Ligand Pharmaceuticals (LGND) Loans and Notes Receivables (2016 - 2018)
Historic Loans and Notes Receivables for Ligand Pharmaceuticals (LGND) over the last 4 years, with Q1 2018 value amounting to $3.9 million.
- Ligand Pharmaceuticals' Loans and Notes Receivables changed N/A to $3.9 million in Q1 2018 from the same period last year, while for Mar 2018 it was $3.9 million, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2017, which is 2089.18% up from last year.
- Latest data reveals that Ligand Pharmaceuticals reported Loans and Notes Receivables of $3.9 million as of Q1 2018.
- Ligand Pharmaceuticals' Loans and Notes Receivables' 5-year high stood at $5.5 million during Q2 2015, with a 5-year trough of $3.0 million in Q3 2017.
- Its 4-year average for Loans and Notes Receivables is $4.0 million, with a median of $3.9 million in 2017.
- In the last 5 years, Ligand Pharmaceuticals' Loans and Notes Receivables tumbled by 4218.5% in 2016 and then surged by 2089.18% in 2017.
- Ligand Pharmaceuticals' Loans and Notes Receivables (Quarter) stood at $4.8 million in 2015, then plummeted by 32.94% to $3.2 million in 2016, then grew by 20.89% to $3.9 million in 2017, then changed by 0.0% to $3.9 million in 2018.
- Its last three reported values are $3.9 million in Q1 2018, $3.9 million for Q4 2017, and $3.0 million during Q3 2017.